Patent Oppositions in mixed drugs industry

Explore the competitive field of mixed drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in mixed drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the mixed drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the mixed drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
A1At For Reducing Risk Of Onset Of Acute Graft Versus Host Disease After Hematopoeitic Cell TransplantationCSL BEHRINGJul 28, 2026OCTAPHARMA
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 21, 2026GENERICS UK
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 20, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 14, 2026SANDOZ
Methods Of Treating Heart Failure With Reduced Ejection Fraction With DapagliflozinASTRAZENECAJul 1, 2026BUSSE & BUSSE
Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen DiseasesTRAVERE THERAPEUTICSJun 30, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMAJun 17, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Drug Delivery Systems And Methods For Treatment Of Bladder Cancer With GemcitabineTARIS BIOMEDICALJun 10, 2026GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBB
Dietary Modulation Of Brain FunctioningNUTRICIAMay 12, 2026NESTLE
Methods For Treating Nasal Polyposis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYMay 6, 2026ENGELHARD

To stay ahead in the competitive mixed drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the mixed drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY24
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS19
Oct 11, 2023New UseNOVARTIS18
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI MATURE15
Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH11
Oct 30, 2019New UseNOVARTIS10
Sep 14, 2022Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM10
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS9
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9